Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maximilian Lennartz

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
Aging|June 4, 2021
Prevalence of proliferating CD8<sup>+</sup> cells in normal lymphatic tissues, inflammation and cancerNiclas C Blessin, Raed Abu-Hashem, Tim Mandelkow, et al.
Diagnostics (Basel, Switzerland)|July 15, 2026
MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor EntitiesViktor Reiswich, Henry Recksiek, Katharina Möller, et al.
Virchows Archiv : an International Journal of Pathology|September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implicationsCosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Archives of Pathology & Laboratory Medicine|August 2, 2022
SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsDavid Dum, Daniela Kromm, Maximilian Lennartz, et al.
Oncology Letters|August 20, 2019
Expression of the immune checkpoint receptor TIGIT in seminomaAndrea Hinsch, Niclas C Blessin, Ronald Simon, et al.
Annals of Diagnostic Pathology|February 10, 2025
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypesPiero Caneve, Nina Schraps, Katharina Möller, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumorsSimon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 TumorsAnne Menz, Nora Lony, Maximilian Lennartz, et al.
Disease Markers|February 9, 2019
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and CancerNiclas C Blessin, Ronald Simon, Martina Kluth, et al.
Analytical Cellular Pathology (Amsterdam)|August 22, 2022
Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 TumorsFlorian Viehweger, Lisa-Marie Tinger, David Dum, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
Aging|June 4, 2021
Prevalence of proliferating CD8<sup>+</sup> cells in normal lymphatic tissues, inflammation and cancerNiclas C Blessin, Raed Abu-Hashem, Tim Mandelkow, et al.
Diagnostics (Basel, Switzerland)|July 15, 2026
MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor EntitiesViktor Reiswich, Henry Recksiek, Katharina Möller, et al.
Virchows Archiv : an International Journal of Pathology|September 24, 2021
Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implicationsCosima Völkel, Noémi De Wispelaere, Sören Weidemann, et al.
Archives of Pathology & Laboratory Medicine|August 2, 2022
SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15 000 TumorsDavid Dum, Daniela Kromm, Maximilian Lennartz, et al.
Oncology Letters|August 20, 2019
Expression of the immune checkpoint receptor TIGIT in seminomaAndrea Hinsch, Niclas C Blessin, Ronald Simon, et al.
Annals of Diagnostic Pathology|February 10, 2025
Brachyury expression is highly specific for chordoma: A tissue microarray study involving 14,976 cancers from 135 different tumor types and subtypesPiero Caneve, Nina Schraps, Katharina Möller, et al.
Acta Oncologica (Stockholm, Sweden)|November 8, 2023
Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumorsSimon Schallenberg, Henning Plage, Sebastian Hofbauer, et al.
Diagnostics (Basel, Switzerland)|May 24, 2024
Epithelial Cell Adhesion Molecule (EpCAM) Expression in Human Tumors: A Comparison with Pan-Cytokeratin and TROP2 in 14,832 TumorsAnne Menz, Nora Lony, Maximilian Lennartz, et al.
Disease Markers|February 9, 2019
Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and CancerNiclas C Blessin, Ronald Simon, Martina Kluth, et al.
Analytical Cellular Pathology (Amsterdam)|August 22, 2022
Diagnostic and Prognostic Impact of Progesterone Receptor Immunohistochemistry: A Study Evaluating More Than 16,000 TumorsFlorian Viehweger, Lisa-Marie Tinger, David Dum, et al.
Pageof 12